Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contraception in Sweden.

F E Riphagen1, B von Schoultz

  • 1International Health Foundation, Geneva, Switzerland.

Contraception
|June 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of cyclooxygenase-1 and cyclooxygenase-2, syndecan-1 and connective tissue growth factor in benign and malignant breast tissue from premenopausal women.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2017
Same author

Peak bone mineral density in Vietnamese women.

Archives of osteoporosis·2010
Same author

IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone.

Reproductive biomedicine online·2009
Same author

Expression of the androgen receptor and syndecan-1 in breast tissue during different hormonal treatments in cynomolgus monkeys.

Climacteric : the journal of the International Menopause Society·2008
Same author

Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.

Maturitas·2008
Same author

Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.

Breast (Edinburgh, Scotland)·2007
Same journal

Comparative effectiveness of 200mcg versus 400mcg misoprostol dosing for medication abortion from 24-27 weeks' gestation.

Contraception·2026
Same journal

Reasons patients decide to replace or extend their long-acting reversible contraceptive before the full duration of pregnancy prevention: a qualitative study.

Contraception·2026
Same journal

Awareness of abortion medications by mail options among abortion patients at 6 clinics: Findings from a pilot study.

Contraception·2026
Same journal

A phase 1, randomized, open-label, single-dose relative bioavailability study of upper arm injection of depot medroxyprogesterone acetate comparing pharmacokinetics and hormone indicators of ovulation with anterior thigh and abdomen injection.

Contraception·2026
Same journal

Associations between pharmacy type, neighborhood disadvantage, and availability and accessibility of an over-the-counter oral contraceptive pill in three Michigan counties.

Contraception·2026
Same journal

Previous caesarean section and major complications during surgical abortion: a national multicentre case-control study.

Contraception·2026
See all related articles

Swedish women aged 15-44 report high contraceptive use (95%), favoring oral contraception. However, significant health concerns negatively impact the image of oral contraceptives and intrauterine devices (IUDs).

Area of Science:

  • Reproductive Health
  • Public Health
  • Sociology

Background:

  • A 1987 survey in Sweden assessed contraceptive use, knowledge, and attitudes.
  • This study was part of a larger multi-country European initiative by the International Health Foundation (IHF).

Purpose of the Study:

  • To evaluate current contraceptive practices among Swedish women aged 15-44.
  • To understand factors influencing method choice and abandonment.
  • To assess user perceptions and knowledge regarding contraceptive safety and efficacy.

Main Methods:

  • A standardized questionnaire was administered to women aged 15-44.
  • Data collection focused on contraceptive use, knowledge of fertility, and attitudes towards various methods.
Keywords:
AttitudeBehaviorContraceptionContraceptive MethodsContraceptive Methods Chosen--determinantsContraceptive UsageDemographic FactorsDeveloped CountriesEuropeFamily PlanningFertilityIudKnowledgeNorthern EuropePopulationPopulation DynamicsPsychological FactorsScandinaviaSweden

Related Experiment Videos

Main Results:

  • Overall contraceptive use was high at 95%, with oral contraception being the most popular method.
  • Barrier methods and intrauterine devices (IUDs) were also frequently used.
  • Health concerns and reliability were primary drivers for choosing or discontinuing methods.
  • Knowledge of fertility was generally good among participants.
  • Oral contraceptives were associated with fears of cardiovascular risks, thrombosis, and cancer.
  • Intrauterine devices (IUDs) were linked to perceived risks of infection and menorrhagia.

Conclusions:

  • Despite high usage, oral contraceptives and IUDs possess a significantly negative image among Swedish users due to perceived health risks.
  • Public perception of these medical methods may influence future contraceptive choices and adherence.